HIV/AIDS Vaccine
Subtype B and E gp120-based vaccines safe and effective for Thai recipients
Published in AIDS Weekly, July 28th, 2003
Punnee Pitisuttithum and colleagues at Mahidol University in Bangkok and other institutions in Thailand and the United States assessed the "safety and immunogenicity of two recombinant human immunodeficiency virus (HIV) type 1 envelope glycoprotein (gp) 120 vaccines derived from SF2 (subtype B) and CM235 (CRF01_AE, Thai E)".
Vaccine recipients demonstrated robust cellular and humoral activity against HIV gp120, Pitisuttithum and coauthors said.
In their study, a group of 370 Thai adults were immunized...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-07-28)
More Articles from AIDS Weekly
- HIV/AIDS Therapy
Novel agents active against NNRTI-resistant viruses - HIV/AIDS Immunology
CD28 expression on CD4 cells may be useful progression marker - HIV/AIDS Therapy
C-terminal octylation improves T20 efficacy - HIV/AIDS Therapy
Novel inhibitory antibodies isolated - HIV/AIDS Vaccine
Chimeric influenza HA/SHIV virus-like particles show promise for mucosal immunization - AIDS Funding
Kenya NGOs see stiff competition for HIV/AIDS money - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
